NOVIZIO, NUNZIA
 Distribuzione geografica
Continente #
AS - Asia 310
NA - Nord America 218
EU - Europa 171
SA - Sud America 30
AF - Africa 3
Totale 732
Nazione #
SG - Singapore 239
US - Stati Uniti d'America 216
IT - Italia 52
RU - Federazione Russa 47
DE - Germania 35
BR - Brasile 29
CN - Cina 21
VN - Vietnam 19
IE - Irlanda 12
IN - India 10
HK - Hong Kong 9
CZ - Repubblica Ceca 6
FI - Finlandia 6
KR - Corea 4
NL - Olanda 4
GB - Regno Unito 2
JP - Giappone 2
NP - Nepal 2
PL - Polonia 2
SE - Svezia 2
TR - Turchia 2
AR - Argentina 1
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
LK - Sri Lanka 1
MA - Marocco 1
SN - Senegal 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 732
Città #
Chandler 60
Princeton 30
Ashburn 25
Singapore 22
Munich 21
Salerno 19
Dong Ket 17
Dublin 12
Seattle 10
Dallas 9
Pune 9
Hong Kong 8
Naples 8
Wilmington 7
Ann Arbor 6
Brno 6
Los Angeles 6
Moscow 5
Turku 5
Shanghai 4
Amsterdam 3
Carbonia 3
Santa Clara 3
São Paulo 3
Ansbach 2
Avellino 2
Boardman 2
Columbus 2
Fisciano 2
Hanover 2
Ho Chi Minh City 2
London 2
Phoenix 2
Rio de Janeiro 2
The Dalles 2
Warsaw 2
Acerra 1
Alvorada 1
Andover 1
Araguaína 1
Araxá 1
Araçuaí 1
Bari 1
Boca Toma 1
Bom Jesus de Goiás 1
Boston 1
Brooklyn 1
Camaçari 1
Campinas 1
Canoas 1
Canoinhas 1
Casablanca 1
Charlotte 1
Contagem 1
Cuiabá 1
Dakar 1
Dalian 1
Esslingen am Neckar 1
Etobicoke 1
Falkenstein 1
Florence 1
Fortaleza 1
Gebze 1
Guangzhou 1
Handan 1
Hengshui 1
Izmir 1
Jhāpā 1
Jinhua 1
João Pessoa 1
Kathmandu 1
Landshut 1
Lappeenranta 1
Ludhiana 1
Medina 1
Nanjing 1
Napoli 1
New York 1
Orlando 1
Osaka 1
Osasco 1
Paulínia 1
Piemonte 1
Praia Grande 1
Ribeirão Preto 1
Richmond 1
Rio Branco 1
Salvador 1
San Francisco 1
Sanclerlândia 1
Santo Antônio do Pinhal 1
Santo Domingo Este 1
Sfax 1
Shenzhen 1
Tashkent 1
Taubaté 1
Tokyo 1
Turin 1
Uberlândia 1
Vienna 1
Totale 389
Nome #
Annexin A1 Is Involved in the Antitumor Effects of 5-Azacytidine in Human Oral Squamous Carcinoma Cells 205
Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors 78
Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 56
Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro 56
The procoagulant activity of emoxilane®: A new appealing therapeutic use in epistaxis of the combination of sodium hyaluronate, silver salt, α-tocopherol and d-panthenol 56
Anxa1 contained in evs regulates macrophage polarization in tumor microenvironment and promotes pancreatic cancer progression and metastasis 56
Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells 55
The promising pro-healing role of the association of mesoglycan and lactoferrin on skin lesions 49
The Protecting Activity of RIPACUT®: A New Therapeutic Approach Preserving Epithelial Health Based on the Combination of Iceland Lichen Extract, Silver Salt, and Sodium Hyaluronate 36
The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk 33
The pyrazolyl-urea gege3 inhibits the activity of ANXA1 in the angiogenesis induced by the pancreatic cancer derived EVs 32
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity 29
The pro-healing effects of heparan sulfate and growth factors are enhanced by the heparinase enzyme: New association for skin wound healing treatment 15
Metformin radiosensitizes OSCC in 2D and 3D models: possible involvement of CAF-1 13
Totale 769
Categoria #
all - tutte 3.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 1 0 0 8 1 2 1 0 30
2021/202272 7 0 0 13 7 3 0 2 3 0 7 30
2022/2023132 10 22 5 25 9 24 0 8 12 4 10 3
2023/202496 5 6 3 1 3 25 8 15 2 3 2 23
2024/2025421 5 7 2 7 7 27 48 9 38 31 133 107
2025/20265 5 0 0 0 0 0 0 0 0 0 0 0
Totale 769